A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 51
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : NMC
Long Form : NUT midline carcinoma
No. Year Title Co-occurring Abbreviation
2019 NUT midline carcinoma of the head and neck: current perspectives. ---
2019 Tumor Mutation Burden and Checkpoint Immunotherapy Markers in NUT Midline Carcinoma. IHC, PD1, TMB, WES
2018 Analysis of DNA methylation and microRNA expression in NUT (nuclear protein in testis) midline carcinoma of the sinonasal tract: a clinicopathological, immunohistochemical and molecular genetic study. CK, miRNA, NUT
2018 Genetic modifiers of the BRD4-NUT dependency of NUT midline carcinoma uncovers a synergism between BETis and CDK4/6is. BET, KLF4
2018 miR-3140 suppresses tumor cell growth by targeting BRD4 via its coding sequence and downregulates the BRD4-NUT fusion oncoprotein. BRD4, CDS, miRNAs
2017 Deciphering the Role of microRNAs in BRD4-NUT Fusion Gene Induced NUT Midline Carcinoma. miRNA
2017 Dual HDAC and PI3K Inhibitor CUDC-907 Downregulates MYC and Suppresses Growth of MYC-dependent Cancers. DH, DLBCL, HDAC, PDX, PI3K
2017 Ectopic protein interactions within BRD4-chromatin complexes drive oncogenic megadomain formation in NUT midline carcinoma. ---
2017 Molecular-genetic profiling and high-throughput in vitro drug screening in NUT midline carcinoma-an aggressive and fatal disease. ---
10  2017 NUT midline carcinoma of the larynx: an international series and review of the literature. FISH, RT-PCR
11  2017 NUT Midline Carcinoma of the Sublingual Gland: Clinical Presentation and Review. ---
12  2017 Pediatric NUT-midline carcinoma: Therapeutic success employing a sarcoma based multimodal approach. ---
13  2017 Systematic Kinase Inhibitor Profiling Identifies CDK9 as a Synthetic Lethal Target in NUT Midline Carcinoma. CDK9i
14  2017 Uncommon somatic mutations in metastatic NUT midline carcinoma. BRD4, DCC, MLL3, NUT, SF3B1
15  2016 Clinical Response of Carcinomas Harboring the BRD4-NUT Oncoprotein to the Targeted Bromodomain Inhibitor OTX015/MK-8628. BET, BRD
16  2016 Cytopathologic features of NUT midline carcinoma: A series of 26 specimens from 13 patients. NUT
17  2016 NUT midline carcinoma mimicking a germ cell tumor: a case report. ---
18  2016 Small-Molecule Targeting of BET Proteins in Cancer. ---
19  2016 The Gross Appearance of a NUT Midline Carcinoma. ---
20  2016 The Oncoprotein BRD4-NUT Generates Aberrant Histone Modification Patterns. B4N, PTM
21  2015 A case of endobronchial NUT midline carcinoma with intraluminal growth. ---
22  2015 A novel BRD4-NUT fusion in an undifferentiated sinonasal tumor highlights alternative splicing as a contributing oncogenic factor in NUT midline carcinoma. BRD4
23  2015 Histone deacetylase inhibitor for NUT midline carcinoma. HDACi, NUT
24  2015 Impressive Response to Dose-Dense Chemotherapy in a Patient with NUT Midline Carcinoma. ---
25  2015 Mechanistic analysis of the role of bromodomain-containing protein 4 (BRD4) in BRD4-NUT oncoprotein-induced transcriptional activation. BRD4, CBP
26  2015 Primary Pulmonary NUT Midline Carcinoma: Clinical, Radiographic, and Pathologic Characterizations. ---
27  2015 Staging and evaluation of neoadjuvant chemotherapy response with ⁸F-FDG PET/CT in NUT-midline carcinoma in a child: a case report and review of the literature. ---
28  2015 The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains. TAD
29  2014 A case of NUT midline carcinoma with complete response to gemcitabine following cisplatin and docetaxel. ---
30  2014 Activation of SOX2 expression by BRD4-NUT oncogenic fusion drives neoplastic transformation in NUT midline carcinoma. ---
31  2014 Comparative drug screening in NUT midline carcinoma. FP
32  2014 MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma. ---
33  2014 NSD3-NUT fusion oncoprotein in NUT midline carcinoma: implications for a novel oncogenic mechanism. ---
34  2014 NUT midline carcinoma: a case report with a novel translocation and review of the literature. ---
35  2013 A case of NUT midline carcinoma with no HPV infection, slight EWSR1 rearrangement and strong expression of EGFR. ---
36  2013 The importance of diagnosing NUT midline carcinoma. HDACi
37  2012 Clinicopathologic features and long-term outcomes of NUT midline carcinoma. CI, OS, PFS
38  2012 NUT midline carcinomas of the sinonasal tract. ---
39  2012 Pathogenesis of NUT midline carcinoma. ---
40  2012 Radiologic features of NUT midline carcinoma in an adolescent. ---
41  2012 [Utility of NUT gene expression and rearrangement in diagnosis of NUT midline carcinoma in upper respiratory tract]. EBER, FISH
42  2011 Differentiation of NUT midline carcinoma by epigenomic reprogramming. HDACi
43  2011 New developments in the molecular pathogenesis of head and neck tumors: a review of tumor-specific fusion oncogenes in mucoepidermoid carcinoma, adenoid cystic carcinoma, and NUT midline carcinoma. ACC, MEC
44  2011 NUT midline carcinoma: case report and review of the literature. ---
45  2011 Perturbation of BRD4 protein function by BRD4-NUT protein abrogates cellular differentiation in NUT midline carcinoma. AP-1, NUT, P-TEFb
46  2010 BRD4-NUT carcinoma of the mediastinum in a pediatric patient: multidetector computed tomography imaging findings. NUT
47  2010 Demystified molecular pathology of NUT midline carcinomas. NUT
48  2010 NUT gene rearrangement in a poorly-differentiated carcinoma of the submandibular gland. NUT
49  2010 NUT midline carcinoma in a newborn with multiorgan disseminated tumor and a 2-year-old with a pancreatic/hepatic primary. ---
50  2010 NUT midline carcinoma. ---
51  2009 Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody. FISH, IHC, NUT